Pay in 4 interest-free payments of $6.62 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
This section is intended for contextual awareness only
Tirzepatide actually activates both GLP-1 and GIP receptors, making it a dual-acting medication with a somewhat stronger effect on the digestive system
Semaglutide carries a boxed warning regarding thyroid C-cell tumors and is contraindicated in patients with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
The duration of treatment is personalized based on your individual weight loss goals and medical needs
US$ 29.23
US$ 23.76
US$ 28.77
US$ 25.26
US$ 19.99
US$ 20.41
US$ 29.29
US$ 28.95
